Posted by Michael Wonder on 19 Jul 2025
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
18 July 2025 - The MHRA has today approved adrenaline nasal spray (EURneffy) to be used for the emergency treatment of serious allergic reactions, known as anaphylaxis.
This medicine has been approved through the International Recognition Procedure (IRP). The IRP allows the MHRA to consider the expertise and decision-making of trusted regulatory partners for the benefit of UK patients.
